Article in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05282082 (A Smart Surveillance Strategy for Carbapenem-resistant Pseudomonas Aeruginosa), which is not on this map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Smart Surveillance Strategy for Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.
TypeobservationalSponsorErasmus Medical CenterRan2022 to 2024Enrolled2,105ConditionsPseudomonas Aeruginosa, Colonization, Asymptomatic, Nosocomial Infection
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
24 authors.
Anneloes van VeenDepartment of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID 0009-0007-9018-8236
Selvi N ShahabDepartment of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID 0009-0001-5119-2677
Amber RijfkogelDepartment of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID 0009-0007-6238-4336
Anne F Voor In 't HoltDepartment of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0002-3560-1725
Corné H W KlaassenDepartment of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0002-3439-0903
Margreet C VosDepartment of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0002-0496-7038
Yulia Rosa SaharmanDepartment of Clinical Microbiology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo General Hospital, Jakarta 10430, Indonesia.ORCID 0000-0001-6065-0329
Anis KaruniawatiDepartment of Clinical Microbiology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo General Hospital, Jakarta 10430, Indonesia.ORCID 0000-0002-9882-2488
Silvia ZelliDipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Roma, Italy.
Desy De LorenzisDipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Roma, Italy.
Giulia MenchinelliDipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Roma, Italy.ORCID 0000-0003-2953-4084
Giulia De AngelisDipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Roma, Italy.ORCID 0000-0002-7087-7399
Maurizio SanguinettiDipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Roma, Italy.ORCID 0000-0002-9780-7059
Merel KemperCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands.
Sima MohammadiInstitut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Quebec City, QC G1V 0A6, Canada.
Valentine RenaudInstitut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Quebec City, QC G1V 0A6, Canada.
Irena Kukavica-IbruljInstitut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Quebec City, QC G1V 0A6, Canada.
Marianne PotvinInstitut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Quebec City, QC G1V 0A6, Canada.ORCID 0000-0002-8184-0268
Guillaume Q NguyenInstitut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Quebec City, QC G1V 0A6, Canada.
Jeff GauthierInstitut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Quebec City, QC G1V 0A6, Canada.ORCID 0000-0002-2523-2698
Roger C LevesqueInstitut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Quebec City, QC G1V 0A6, Canada.ORCID 0000-0001-8315-5937
Heike SchmittCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands.ORCID 0000-0002-0139-1934
Juliëtte A SeverinDepartment of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0002-5222-3017
Funding
Erasmus+ scholarship 587538International Development Research Centre 109283-001JPI-AMR/ZonMw 549009005
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
antimicrobial drug resistancecarbapenemshospitalshumansOne HealthPseudomonas aeruginosarisk factorswastewater
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Sources and Transmission Routes of Carbapenem-Resistant · full record | OpenQuestion